John D. Fowler Jr.
CIK: 0001190344
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EBS
Emergent BioSolutions Inc.
Director
Discretionary Trading P&L
Holdings
About FOWLER JOHN D JR
FOWLER JOHN D JR (SEC CIK 0001190344) files insider reports with the SEC as Director of Emergent BioSolutions Inc. (EBS).
Signal8 holds 3 ownership filings by FOWLER JOHN D JR (1 Form 3, 2 Form 4), filed between Mar 5, 2026 and May 4, 2026. Those filings report 2 transactions, from Mar 3, 2026 to Apr 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on FOWLER JOHN D JR's filings is in GAITHERSBURG, MD.
Recent filings by FOWLER JOHN D JR
Other insiders filing for Emergent BioSolutions Inc. (EBS)
- DeGolyer Donald W, Director
- Williams Paul Anthony, SVP, Products Business
- Duatschek Stephanie, EVP, CGO
- LINDAHL RICHARD S, EVP, Chief Financial Officer
- Glessner Coleen, EVP, Quality & Ethics, and CPL
- Hartzel William, SVP, Bioservices